For Immediate Release Test Your Clinical Knowledge in the CME Series Clinical CliffhangersSM: Achieving Optimal Diabetes Care |
||||||
BALTIMORE, MD—August 7, 2014—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), invites healthcare professionals to participate in this series of three 30-minute interactive Webisodes, Clinical CliffhangersSM: Achieving Optimal Diabetes Care. Achieving optimal glycemic control and being able to identify the barriers that can lead to clinical inertia is critical for healthcare professionals when treating patients with type 2 diabetes. Med-IQ is offering this complimentary, online CME series to give participants evidence- and guideline-based recommendations for developing comprehensive care plans that include incretin- and insulin-based therapies. The series follows the progression of a patient with type 2 diabetes through different treatment options and discusses the benefits and implications of choosing various therapeutic approaches. Each Webisode ends at a key decision point or clinical complication, giving healthcare professionals the opportunity to apply clinical knowledge to “real-life” case scenarios. “As the prevalence of type 2 diabetes continues to grow in the United States, recognizing the importance of more aggressive treatment strategies has become increasingly important for primary care professionals,” says Dace Trence, MD, Director of the Diabetes Care Center at the University of Washington in Seattle. “Participants in this Clinical CliffhangersSM series will gain strategies for developing more effective individualized treatment plans that lead to optimal glycemic control.”
Clinicians are invited to visit www.med-iq.com/a757 for complimentary access to this educational series. For more information, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. This series is approved for AMA PRA Category 1 Credit™. This series is supported by educational grants from Sanofi-aventis U.S. Inc., A SANOFI COMPANY, and Lilly. For further information concerning Lilly grant funding visit lillygrantoffice.com. For more information, call (toll-free) 866 858 7434 or e-mail info@med-iq.com. |
||||||
About Med-IQ |
||||||
Amy Caswell |